Semagloutide: Lub sijhawm tshiab rau kev kho ntshav qab zib tshiab
Mar 21, 2025
Tso lus
Semaglutide, tus tshiab thiab muaj peev xwm cog lus tias yuav tsum muaj peev xwm ntawm kev kho mob ntshav qab zib hom 2 (t2dm). Rau cov neeg mob ntshav qab zib, cov ntshav ntshav qis yog qhov tseem ceeb rau kev tiv thaiv kev mob nkeeg. Semaglutide ua haujlwm los ntawm kev ua kom lub glucagagon zoo li peptide {3}} (glp} (li exerting zoo cuam tshuam rau ntau txoj kev. Nws tsis tsuas yog txhawb nqa insulin kev zais cia tab sis kuj tseem ncua roj plab, txo cov ntshav ntshav qab zib muaj txiaj ntsig zoo. Cov chaw sim kho mob tau qhia tias cov neeg mob tau kho nrog cov mob ntsws muaj qhov tsis txaus siab tswj ntshav qab zib.
Ntxiv nrog rau nws txoj kev ua tau ntshav hauv cov ntshav qab zib, semagloutide kuj ua rau pom kev tiv thaiv ntawm cov hlab plawv. Rau cov neeg mob uas muaj tus mob ntshav qab zib hom 2 thiab cov tshuaj no tuaj yeem txo qhov kev pheej hmoo ntawm kev tiv thaiv kab mob plawv, thiab tsis muaj kev tiv thaiv kev ua rog, muab kev tiv thaiv kev ua kom tuag taus ntau dua. Both the injectable and oral tablet forms of semaglutide have been approved for the treatment of type 2 diabetes, with the oral tablet offering greater convenience for patients, eliminating the need for injections and improving adherence.
Genohope Biotech Ltd.
Ib tug ua chaw tsim khoom ntawm GLP -1 api
Tus neeg muag khoom los ntawm FDA
Txais tos ib qho kev nug
WhatsApp / Tel: {+8613833133635
Email:info@genohopebio.com
Xa kev nug